We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+3.43%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.79B
AUM Growth
+$618M
Cap. Flow
+$595M
Cap. Flow %
33.32%
Top 10 Hldgs %
16.68%
Holding
4,499
New
1,229
Increased
1,153
Reduced
1,264
Closed
790

Sector Composition

Rank Sector Weight
1 Technology 13.59%
2 Financials 10.04%
3 Healthcare 8.35%
4 Industrials 7.34%
5 Consumer Discretionary 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXPO icon
3126
Exponent
EXPO
$3.24B
$4K ﹤0.01%
80
-844
-91% -$38.7K
FRA icon
3127
BlackRock Floating Rate Income Strategies Fund
FRA
$385M
$4K ﹤0.01%
+300
New +$4.29K
GABC icon
3128
German American Bancorp
GABC
$1.9B
$4K ﹤0.01%
+100
New +$3.55K
GIGM icon
3129
GigaMedia
GIGM
$16.4M
$4K ﹤0.01%
1,200
+823
+218% +$2.35K
GILT icon
3130
Gilat Satellite Networks
GILT
$848M
$4K ﹤0.01%
480
+421
+714% +$3.53K
GPRO icon
3131
GoPro
GPRO
$126M
$4K ﹤0.01%
612
-21,284
-97% -$119K
GYRE icon
3132
Gyre Therapeutics
GYRE
$744M
$4K ﹤0.01%
+50
New +$8.77K
HCI icon
3133
HCI Group
HCI
$2.41B
$4K ﹤0.01%
102
-20,728
-100% -$858K
HCKT icon
3134
Hackett Group
HCKT
$287M
$4K ﹤0.01%
257
-2,745
-91% -$44.6K
IGR
3135
CBRE Global Real Estate Income Fund
IGR
$713M
$4K ﹤0.01%
+572
New +$4.24K
IGSB icon
3136
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
$4K ﹤0.01%
76
-180
-70% -$9.33K
KALA icon
3137
KALA BIO
KALA
$14.5M
0
KIDS icon
3138
OrthoPediatrics
KIDS
$595M
$4K ﹤0.01%
140
-3,052
-96% -$65.1K
KNSA icon
3139
Kiniksa Pharmaceuticals
KNSA
$5.93B
$4K ﹤0.01%
+230
New +$4.16K
KOPN icon
3140
Kopin
KOPN
$791M
$4K ﹤0.01%
1,351
-10,559
-89% -$34.8K
KOS icon
3141
Kosmos Energy
KOS
$1.48B
$4K ﹤0.01%
+511
New +$3.73K
LPTH icon
3142
Lightpath Technologies
LPTH
$820M
$4K ﹤0.01%
+1,688
New +$3.62K
LSBK icon
3143
Lake Shore Bancorp
LSBK
$134M
$4K ﹤0.01%
256
-137
-35% -$2.36K
MDXG icon
3144
MiMedx Group
MDXG
$633M
$4K ﹤0.01%
608
-4,849
-89% -$34.5K
MLR icon
3145
Miller Industries
MLR
$619M
$4K ﹤0.01%
156
-1,892
-92% -$49.2K
MODV
3146
DELISTED
ModivCare
MODV
$4K ﹤0.01%
+50
New +$3.75K
MSEX icon
3147
Middlesex Water
MSEX
$1.1B
$4K ﹤0.01%
+100
New +$4.14K
NAII icon
3148
Natural Alternatives International
NAII
$14.9M
$4K ﹤0.01%
403
-706
-64% -$7.45K
NGNE icon
3149
Neurogene
NGNE
$712M
$4K ﹤0.01%
+67
New +$17.5K
NMM icon
3150
Navios Maritime Partners
NMM
$2.26B
$4K ﹤0.01%
+125
New +$3.41K

Similar funds

Tower Research Capital (TRC)'s Q2 2018 Portfolio in Review

As of Q2 2018, Tower Research Capital (TRC) held 4,499 positions worth $1.79B, up 53% from $1.17B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Tower Research Capital (TRC) deployed $595M of net new capital in Q2 2018, opening 1,229 new positions and adding to 1,153 existing holdings. Its largest new stake was JPMorgan Chase: 180,678 shares worth $18.8M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 4.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $31.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2018 buy was JPMorgan Chase: 180,678 shares worth $18.8M.
  • Tower Research Capital (TRC) added most to Apple in Q2 2018, an estimated $51.7M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2018 reduction was iShares MSCI EAFE ETF, cutting an estimated $31.8M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Dow Jones REIT ETF in Q2 2018, selling an estimated $6.85M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 17% of its $1.79B portfolio in Q2 2018.
  • Tower Research Capital (TRC) opened 1,229 new positions and closed 790 in Q2 2018.
  • Tower Research Capital (TRC)'s portfolio value rose 53% quarter-over-quarter to $1.79B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2018, filed 15 Aug 2018.